Know what’s really happening atContraline before you sign on.

  • On the roadmap
  • Reproductive Health
  • Medical Devices
  • Biotechnology

Contraline is developing ADAM™, a reversible, non-hormonal implantable contraceptive for men — a category with virtually no modern options. Backed by Founders Fund, Google Ventures, and RA Capital Management, the clinical-stage company is pursuing one of the largest unmet needs in reproductive health.

How we do it.

Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.

Contraline

Total funding raised
$117.13M
Series B round (June 2026)
$92.5M
Year founded
2015
Headquarters
Charlottesville, Virginia, United States
Employee count
30
Funding rounds completed
9
Company size range
11-50

Press reported

Altis Verified

What's in the report

Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.

  1. Market Overview

    Market structure, where the company sits, and growth drivers.

    • market map
    • Reproductive Health landscape
    • Reproductive Health growth rate
    • CAGR
  2. Total Addressable Market

    Bottom-up TAM / SAM / SOM.

    • Contraline TAM
    • Reproductive Health market size
    • market opportunity
  3. Company Overview

    What the company does and how it operates.

    • what does Contraline do
    • Contraline product
    • business model
  4. Product / Go-to-Market

    Product, GTM motion, ICP, and who buys.

    • Contraline customers
    • who uses Contraline
    • Contraline ICP
    • go-to-market
  5. Competitive Dynamics

    The Altis Market Map and the Altis Win-Rate Index.

    • Contraline competitors
    • Contraline alternatives
    • who competes with Contraline
    • Contraline win rate
  6. Customer Signals

    Retention, satisfaction, and win/loss signals.

    • Contraline reviews
    • Contraline NRR
    • Contraline churn
    • current customers
    • switching costs
  7. Investment Debates

    Investment thesis, moat, bull/bear, and key risks.

    • Contraline investment thesis
    • Contraline moat
    • bull case bear case
    • Contraline risk factors
  8. Monetization & Financials

    Business model, revenue model, and unit economics.

    • Contraline ARR
    • Contraline revenue
    • Contraline valuation
    • unit economics
  9. Team and culture

    Founders, leadership, and org.

    • Contraline founders
    • Contraline CEO background
    • leadership team
    • headcount

Trusted by

Primary Venture PartnersEmergence CapitalFounders Circle CapitalGeneral AtlanticFika VenturesSentinel GlobalSapphire VenturesVerified CapitalDiffusion

Ready to see the full picture?

Profile based on Altis company screening data and verified public information as of July 2026.